UMIN-CTR Clinical Trial

Basic information
Official scientific title of the study	The verification study for the blood lipid reduction effects of garlic egg yolk: a randomized, double-blind, controlled trial
Title of the study (Brief title)	The verification study for the blood lipid reduction effects of garlic egg yolk
Region	Japan

Condition
Condition	Healthy adults
Classification by specialty	Not applicable Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	To verify the blood lipid reduction effects due to the ingestion of the test food.
Basic objectives2	Safety,Efficacy
Basic objectives -Others
Trial characteristics_1	Exploratory
Trial characteristics_2	Explanatory
Developmental phase	Not applicable

Assessment
Primary outcomes	1. LDL-cholesterol *1 Take the blood samples at 0 week and at 6 and 12 weeks after the ingestion
Key secondary outcomes	1. Total cholesterol, HDL-cholesterol, LDL/HDL ratio, Neutral fat (triglyceride: TG), Free fatty acid, MDA-LDL *1 Take the blood samples at 0 week and at 6 and 12 weeks after the ingestion 2. Body weight, BMI, Body fat percentage *2 Take the measurements at 0 week and at 6 and 12 weeks after the ingestion

Base
Study type	Interventional

Study design
Basic design	Parallel
Randomization	Randomized
Randomization unit	Individual
Blinding	Double blind -all involved are blinded
Control	Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	2
Purpose of intervention	Treatment
Type of intervention	Food
Interventions/Control_1	Duration: 12 weeks Test material:"Garlic egg yolk 229-55 ninnikugogo" Dose: Take one capsule, three times a day Administration: Take one capsule after each meal
Interventions/Control_2	Duration: 12 weeks Test material: Placebo Dose: Take one capsule, three times a day Administration: Take one capsule after each meal
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	Not applicable
Gender	Male and Female
Key inclusion criteria	1. LDL-cholesterol level was high in the most recent health diagnosis
Key exclusion criteria	1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Currently taking medicines and/or herbal medicines 4. Allergic to medicines or foods related to the test food of this trial 5. Pregnant, lactating, or planning to get pregnant during the trial period 6. Enrolled into other clinical trials within the last 3 months before agreeing to participate in this trial 7. Judged unsuitable for participating in this trial by physician
Target sample size	50

Research contact person
Name of lead principal investigator	Kazuo YAMAMOTO
Organization	ORTHOMEDICO, Inc.
Division name	R&D Department
Address	2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.
TEL	03-3818-0610
Email	kazu@orthomedico.jp

Public contact
Name of contact person	Naoko SUZUKI
Organization	ORTHOMEDICO, Inc.
Division name	R&D Department
Address	2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.
TEL	03-3818-0610
Homepage URL
Email	nao@orthomedico.jp

Sponsor
Institute	ORTHOMEDICO, Inc.
Institute
Department

Funding Source
Organization	Temahimado Co., Ltd.
Organization
Division
Category of Funding Organization	Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor	1. Seishin-kai Medical Association Inc, Takara Medical Clinic. 2. Evaluation Center of Health and Nutrition Inc.
Name of secondary funｄer(s)

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions	医療法人社団 盛心会 タカラクリニック (東京都) Seishin-kai Medical Association Inc, Takara Medical Clinic (Tokyo)

Other administrative information
Date of disclosure of the study information	2017 Year 07 Month 28 Day

Progress
Recruitment status	Completed
Date of protocol fixation	2015 Year 04 Month 21 Day
Anticipated trial start date	2015 Year 04 Month 22 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results	Published
URL releasing results
Results	Suzuki N, Yamamoto K, Kakino K, Takara T. The Effects of Administration of Garlic-egg Yolk-containing Supplements on Serum Lipid Level in Humans -A Randomized, Double-blind, Placebo-controlled Trial-. Jpn Pharmacol Ther. 2016; 44(11): 1645-1653.
Other related information

Management information
Registered date	2016 Year 08 Month 18 Day
Last modified on	2017 Year 02 Month 01 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027261